Brief: Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
02/09/2026 23:27
BRIEF-Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) Sept 2 (Reuters) - Dianthus Therapeutics Inc DNTH.O:
DIANTHUS THERAPEUTICS ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)
Source text: ID:nGNX41MjRp
Further company coverage: DNTH.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Dianthus Therapeutics
See all newsU.S. RESEARCH ROUNDUP- Adobe, Chewy, Mosaic
Brief: Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
U.S. RESEARCH ROUNDUP- Berkshire Hathaway, Exxon Mobil, Honeywell Technologies
Dianthus Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Dianthus Therapeutics Q2 net loss widens as R&D costs rise